Rigel Pharmaceuticals | RIGL - Ebitda





Ebitda تغيير تاريخ
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.8B 1.25B 2026-09
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Celldex Therapeutics USD -79.72M 3.86M 2026-06
Daiichi Sankyo JPY 116.06B 14.46B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
MacroGenics USD -64.54M 34.34M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Pfizer USD 6.36B 350M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Veracyte USD 41.24M 2.72M 2026-09